Looking back, it's hard to argue that capitation models have plenty of flaws--but of late, they seem to be creeping back into the consciousness of health executives, legislators and policymakers ...
CEO Daniel Virnich highlighted a strong start to the year, reporting "revenue for Q1 increased by 10% versus the prior year period," mainly driven by robust performance in the retail Pharmacy and ...